Get Dengue Fever Vaccine in Bangkok, Chiang Mai, Pattaya, Phuket, Koh Samui, Thailand

Dengue fever is a life-threatening disease affecting people of all ages, particularly in tropical regions like Thailand. Protecting yourself is essential, and vaccination is a powerful tool in this effort. The new Qdenga vaccine provides a comprehensive solution, offering protection without requiring prior dengue infection or immunity tests.

Whether you're a resident or a traveller, you can easily access the Qdenga vaccine at PULSE Clinic in Bangkok, Chiang Mai, Pattaya, Phuket, or Koh Samui. Book your appointment today and stay safe from dengue fever!

Preventive Measures

In addition to vaccination, you can minimise your risk of dengue fever by:

• Using mosquito repellents with DEET.
• Wearing long-sleeved shirts and pants.
• Sleeping under mosquito nets, especially in rural areas.
• Eliminating standing water around your home or accommodation.

Dengue fever is a major health threat in Thailand, affecting thousands each year, but with the new Qdenga vaccine, you can protect yourself and your loved ones. Worried about dengue fever? PULSE Clinic offers the Qdenga vaccine for your protection.

Price of the dengue vaccine at PULSE Clinic

Take the first step to protect yourself—book your appointment today at PULSE Clinic and stay safe from dengue fever.

Contact us at info.bkk@pulse-clinic.com or chat on your preferred platform:

 +66 65 237 1936    @PULSEClinic   PulseClinic

What is the Qdenga Vaccine for Dengue Fever?

Qdenga is a live-attenuated vaccine specifically designed to combat dengue fever. It targets the second strain of the dengue virus (DENV-2), which serves as the genetic backbone of this vaccine and is one of the most common strains found in Thailand. Once vaccinated, Qdenga activates the body’s immune system to protect against all four dengue virus serotypes.

This vaccine is a significant step in preventing dengue fever, a disease prevalent in tropical regions like Thailand, especially during the rainy season.

How Many Injections Are Needed?

The Qdenga vaccine requires two doses, administered as subcutaneous injections in the upper arm. These doses must be given three months apart: one at the initial visit (Month 0) and the second three months later (Month 3).

Common Side Effects of the Qdenga Vaccine

Side effects are typically mild and appear within the first two days after the injection. They usually resolve on their own within 3–4 days. Common side effects include:

• Injection Site Reactions: Pain, redness, warmth, and swelling at the injection site.
• Systemic symptoms: fever, headache, and general body aches.

It’s advisable to rest, stay hydrated, and take mild pain relievers, such as paracetamol if needed.

What Are the Benefits of the Qdenga Vaccine?

The Qdenga vaccine offers several advantages:

• Comprehensive Protection: Provides 80% protection against all four dengue virus serotypes—DENV-1, DENV-2, DENV-3, and DENV-4. This helps shield you from the four major strains of the virus found in Thailand.
• Reduced Hospitalisations: Lowers the hospitalisation rate by up to 90.4%.
• Severity Reduction: Decreases the severity of dengue fever by 85.9%.
• No Pre-Vaccine Testing Required: No need for prior testing for dengue immunity.
• Wide Age Range: Suitable for individuals aged 4 to 60 years.
• No Prior Dengue History Needed: This can be administered regardless of whether the individual has had dengue fever before.

This vaccine is particularly beneficial for individuals residing in or travelling to high-risk dengue zones, including Thailand's cities and islands such as Bangkok, Chiang Mai, Pattaya, Phuket, and Koh Samui.

Who Should Get Vaccinated?

The Qdenga vaccine is recommended for:

• Anyone aged 4 to 60 years.
• Individuals who have never had dengue fever (without the need for a blood test).
• Those seeking long-term protection against dengue.
• No pre-vaccine testing is required.

The vaccination schedule includes 2 doses given three months apart.

Note: Dengue fever cases in Thailand spike during the rainy season (May to October). Getting vaccinated before this period ensures added protection

Limitations and Precautions

The Qdenga vaccine is not suitable for everyone. It should not be administered to:

• Immunocompromised Individuals: Such as those undergoing chemotherapy, using high-dose steroids (e.g., Prednisone 20 mg/day or 2 mg/kg/day for two weeks within the past four months), or living with HIV.
• Allergy-Prone Individuals: Those with a history of severe allergic reactions to vaccine components.
• Pregnant or Breastfeeding Women: Pregnant women and nursing mothers should avoid vaccination. Women of reproductive age should use birth control for at least one month after vaccination.
• History of Sensitivity to Dengue Vaccines: Individuals who have experienced drug hypersensitivity syndrome or adverse reactions to previous dengue vaccines.

If I Had Dengue Fever Before, When Should I Get the Qdenga Vaccine?

If you’ve had dengue fever before, it’s still recommended to get vaccinated since a second dengue infection can be more severe. However, you should wait at least six months after your recovery before receiving the vaccine.

Testing for Dengue: A Key Preventive Measure

In addition to vaccination, testing for dengue is a critical preventive tool.

Testing is significant for those considering the dengue vaccine, as it helps ensure that only individuals with previous infections are vaccinated.

Dengue fever is a growing global health threat, and prevention through vaccination and testing is critical. The Dengvaxia vaccine is highly recommended for adolescents with prior dengue infection living in high-risk areas. In contrast, the Qdenga vaccine offers a more flexible option, protecting a more comprehensive age range without needing pre-vaccination testing. However, both vaccines have specific contraindications and limitations, so it is essential to consult a healthcare provider to determine the best course of action for dengue prevention. Staying in air-conditioned rooms or using insecticide-treated nets can also reduce exposure to mosquitoes.

By combining vaccination with proper testing, we can significantly reduce the incidence and severity of dengue fever and protect vulnerable populations from this severe viral infection.

FAQ About Dengue Vaccine (QDENGA®)

As a traveller to Thailand, should I get the Qdenga® vaccine?

• It is recommended to consult a doctor to discuss the benefits, costs, and potential risks of the Qdenga® vaccine. You can also visit PULSE Clinic for further information. Consulting a healthcare professional is always advised.
• Qdenga® is a relatively new vaccine, and long-term safety data, particularly in larger populations, is currently limited. This should be considered alongside the benefits of vaccination.
• Regardless of whether you choose to get the vaccine, it is essential to protect yourself from mosquito bites. If you experience a high fever or suspect dengue infection, seek medical attention immediately.

How long does Qdenga® protect me?

• There is insufficient scientific data to determine the full duration of Qdenga®'s protection.
• Studies have shown that after 4.5 years, Qdenga® provides 59% effectiveness in preventing dengue fever and 84% effectiveness in preventing hospitalisation due to dengue.
• However, it is still unclear whether the protection will last 10–15 years post-vaccination. More research and data are needed to answer this question definitively.

What is Qdenga®, and in which countries is this vaccine licensed?

• Qdenga® is a live attenuated tetravalent dengue vaccine that protects against all four dengue virus serotypes (DENV-1, DENV-2, DENV-3, and DENV-4). The vaccine uses a live attenuated (weakened) DENV-2 strain as its backbone.
• Qdenga® is registered and available in Thailand (at PULSE Clinic), Indonesia, Brazil, Argentina, the United Kingdom, and the European Union.

Who is eligible for the dengue vaccine?

• Individuals aged 4 to 60 years living in or travelling to dengue-risk areas.
• The vaccine is not recommended for individuals with the following conditions:
  • Allergies to vaccine components.
  • Pregnancy or breastfeeding.
  • Immunocompromised conditions.
  • Cancer or undergoing immunosuppressive treatments.

What is the efficacy of Qdenga®?

• The vaccine is approximately 80% effective in preventing dengue infection.
• It has shown a 90.4% efficacy in preventing hospitalisation due to dengue fever.
• After 4.5 years, Qdenga® demonstrated 59% effectiveness in preventing dengue fever and 84% effectiveness in reducing hospitalisation rates.

What is the cost of Qdenga®, and how many doses are required?

• The cost of the vaccine at PULSE Clinic is approximately 36,000 THB.
• Two doses are required: one on Day 0 and the second on Month 3.
• All travellers must consult with a doctor to obtain a vaccine prescription.
• Appointments are recommended before visiting the clinic to ensure availability and minimise wait times.
  
  

Note: Protecting yourself against dengue fever, whether through vaccination or preventative measures like mosquito repellents and protective clothing, is crucial for staying safe in dengue-endemic areas. For further assistance, reach out to your healthcare provider or PULSE Clinic.

Protect yourself today! Book your dengue vaccine now!

Contact us at info.bkk@pulse-clinic.com or chat on your preferred platform:

 +66 65 237 1936    @PULSEClinic   PulseClinic

Conclusion

The Qdenga vaccine offers a reliable and effective way to protect yourself from dengue fever, especially in regions like Thailand where the disease is common. By reducing hospitalisation rates and the severity of the disease, this vaccine provides peace of mind for both residents and travellers.

Stay protected and plan your vaccination today at PULSE Clinic in Bangkok, Chiang Mai, Pattaya, Phuket, or Koh Samui. Consult a healthcare professional to determine if the Qdenga vaccine suits you.

REFERENCES:

• European Medicine Agency. Qdenga 
• Takeda New Release 2022. https://www.takeda.com/newsroom/newsreleases/2022/takedas-qdenga-dengue-tetravalent-vaccine-live-attenuated-approved-for-use-in-european-union/
• Thai FDA. Qdenga product information